Provided by Tiger Trade Technology Pte. Ltd.

KINTOR PHARMA-B

2.870
+0.0702.50%
Volume:1.81M
Turnover:5.06M
Market Cap:1.43B
PE:-5.60
High:2.870
Open:2.810
Low:2.770
Close:2.800
52wk High:4.700
52wk Low:1.200
Shares:499.00M
HK Float Shares:499.00M
Volume Ratio:0.70
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.513
ROE:-83.96%
ROA:-25.18%
PB:6.80
PE(LYR):-5.60
PS:38.01

Loading ...

Pharmaceutical Retail Sector Shows Clear Turnarounds in Performance and Valuation, Awaiting Multiple Catalysts

Stock News
·
40 mins ago

Fruit and Vegetable Giant's $700 Million Foray into Pharmaceuticals: Can New Controlling Shareholder Turn the Tide?

Deep News
·
Yesterday

GTHT: Favorable Industry Trends Persist in 1Q26, Innovative Drugs Remain Key Driver of Pharmaceutical Sector Momentum

Stock News
·
Yesterday

Multiple Tailwinds Converge, Hong Kong Biotech Sector Enters Favorable Investment Window; FG's HK Connect Healthcare Fund Launches Today

Deep News
·
May 11

Commercial Bribery or Risk Compensation? Insurers Grapple with Pharmaceutical Discounts

Deep News
·
May 11

Industrial Securities Forecasts Pharmaceutical Sector Stabilization in 2025, Growth Continues into Q1 2026

Stock News
·
May 11

Era of Universal Growth Ends for Healthcare Sector, Redefining Survival Thresholds

Deep News
·
May 09

Major A-Share Indices Open Lower; AI Applications, Pharmaceuticals, and Baijiu Lead Gains

Stock News
·
May 08

BIOSTAR PHARM-B Proposes Adoption of Share Option Scheme

Stock News
·
May 07

Beijing Hotgen Biotech's Subsidiary Secures Beijing's "Specialized, Refined, Unique, and Innovative" SME Certification

Stock News
·
May 07

Kintor Pharma Maintains Unchanged Share Capital Structure in April 2026 Monthly Return

Bulletin Express
·
May 06

Pharmaceutical Firm Aibang Medicine Files for Hong Kong IPO with Commercial Product and Global Pipeline

Stock News
·
May 06

Measures to Strengthen Tibetan Medicine Industry

Deep News
·
May 06

China's Pharmaceutical Brands Reach $12.09 Billion in Value on Brand Finance 2026 Global Ranking

Deep News
·
Apr 30

Prospective IPO Analysis: Huilun Pharma's Distant Pipeline Fails to Address Immediate Woes; When Will It Emerge from Transition Pains?

Stock News
·
Apr 30

开拓药业-B聚焦皮肤科创新药与功能性化妆品,多元化布局带动收入大幅增长

Bulletin Express
·
Apr 29

Kintor Pharma’s 2025 ESG Report Shows 6.5% Greenhouse-Gas Cut and Tightened Supply-Chain Oversight

Bulletin Express
·
Apr 29

Kintor Pharmaceutical publishes 2025 ESG report

Reuters
·
Apr 29

ZhongOu Fund Appoints Tech Specialist Dai Yunfeng to Succeed Ge Lan as Manager of Mingrui New Starting Fund

Deep News
·
Apr 29

BIOSTAR PHARM-B Proposes Appointment of Zhu Xiaodong as Independent Non-Executive Director

Stock News
·
Apr 28